CTI BioPharma Corp. CTIC

Quarterly report 2023-Q1
added 05-15-2023

CTI BioPharma Corp. DIO Ratio 2011-2026 | CTIC

Annual DIO Ratio CTI BioPharma Corp.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
38.1	-	-	-	-	552	404	535	1.71 K	13.5 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
13.5 K	38.1	2.79 K

Quarterly DIO Ratio CTI BioPharma Corp.

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
56.3	-	73.2	40	16.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43.8	-	-	761	643	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
761	16.7	234

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Biogen BIIB	394	$ 177.93	-4.15 %	$ 25.9 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	AstraZeneca PLC AZN	206	$ 94.4	0.82 %	$ 96.9 B	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Bristol-Myers Squibb Company BMY	68.2	$ 55.84	0.13 %	$ 113 B	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Caladrius Biosciences CLBS	35.8	-	-16.75 %	$ 25.8 M	USA
	Catalyst Biosciences CBIO	410	$ 11.09	1.0 %	$ 730 M	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Coherus BioSciences CHRS	116	$ 1.69	2.12 %	$ 159 M	USA
	Amphastar Pharmaceuticals AMPH	132	$ 28.99	-1.39 %	$ 1.4 B	USA
	Cellectis S.A. CLLS	23.3	$ 4.24	-0.47 %	$ 116 M	France
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA